Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.54 EUR | -2.31% | -0.78% | +38.04% |
May. 10 | Met.Extra Group closes 2023 with falling indicators | AN |
May. 08 | Met.Extra bullish; Bioera gives way. | AN |
Valuation
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 15.74 | 7.056 | 7.084 | 6.948 | 8.386 | 17.28 |
Enterprise Value (EV) 1 | 15.86 | 6.999 | 7.082 | 6.985 | 8.445 | 31.1 |
P/E ratio | 52.3 x | -41.1 x | -17 x | 451 x | -81.4 x | 6.05 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 212 x | 8.76 x | 10.6 x | 7.94 x | 13.3 x | 0.35 x |
EV / Revenue | 214 x | 8.69 x | 10.6 x | 7.98 x | 13.4 x | 0.62 x |
EV / EBITDA | -12.3 x | 331 x | -38.6 x | 95.8 x | 281 x | 6.23 x |
EV / FCF | -7.53 x | -184 x | 291 x | -18.6 x | 420 x | -2.13 x |
FCF Yield | -13.3% | -0.54% | 0.34% | -5.37% | 0.24% | -47% |
Price to Book | 84.4 x | 14 x | 46.1 x | 13.4 x | 20.2 x | 0.72 x |
Nbr of stocks (in thousands) | 1,357 | 1,357 | 1,357 | 1,357 | 1,357 | 4,214 |
Reference price 2 | 11.60 | 5.200 | 5.220 | 5.120 | 6.180 | 4.100 |
Announcement Date | 5/16/18 | 6/8/19 | 6/5/20 | 6/4/21 | 5/25/22 | 5/30/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 0.0742 | 0.8053 | 0.6687 | 0.8755 | 0.6323 | 50.05 |
EBITDA 1 | -1.293 | 0.0211 | -0.1834 | 0.0729 | 0.0301 | 4.992 |
EBIT 1 | -1.433 | -0.0159 | -0.2204 | 0.0509 | -0.0689 | 4.718 |
Operating Margin | -1,931.05% | -1.97% | -32.97% | 5.81% | -10.9% | 9.43% |
Earnings before Tax (EBT) 1 | 0.4033 | -0.0788 | -0.2897 | 0.047 | -0.0703 | 4.717 |
Net income 1 | 0.3012 | -0.1717 | -0.416 | 0.0154 | -0.1031 | 2.858 |
Net margin | 405.86% | -21.32% | -62.22% | 1.76% | -16.3% | 5.71% |
EPS 2 | 0.2220 | -0.1266 | -0.3066 | 0.0114 | -0.0760 | 0.6782 |
Free Cash Flow 1 | -2.107 | -0.0381 | 0.0243 | -0.3751 | 0.0201 | -14.62 |
FCF margin | -2,838.67% | -4.73% | 3.64% | -42.84% | 3.18% | -29.22% |
FCF Conversion (EBITDA) | - | - | - | - | 66.88% | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 5/16/18 | 6/8/19 | 6/5/20 | 6/4/21 | 5/25/22 | 5/30/23 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | 0.12 | - | - | 0.04 | 0.06 | 13.8 |
Net Cash position 1 | - | 0.06 | 0 | - | - | - |
Leverage (Debt/EBITDA) | -0.0945 x | - | - | 0.5044 x | 1.954 x | 2.769 x |
Free Cash Flow 1 | -2.11 | -0.04 | 0.02 | -0.38 | 0.02 | -14.6 |
ROE (net income / shareholders' equity) | -45.9% | -49.7% | -126% | 4.59% | -22.1% | 27.6% |
ROA (Net income/ Total Assets) | -32.8% | -0.6% | -11% | 2.43% | -2.92% | 13.2% |
Assets 1 | -0.9179 | 28.78 | 3.78 | 0.6351 | 3.531 | 21.66 |
Book Value Per Share 2 | 0.1400 | 0.3700 | 0.1100 | 0.3800 | 0.3100 | 5.670 |
Cash Flow per Share 2 | 0.0500 | 0.0400 | 0 | 0.0500 | 0.0300 | 0.1000 |
Capex | - | - | - | 0 | 0 | 1.47 |
Capex / Sales | - | - | - | 0.11% | 0.16% | 2.94% |
Announcement Date | 5/16/18 | 6/8/19 | 6/5/20 | 6/4/21 | 5/25/22 | 5/30/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+38.04% | 11.53M | |
+11.36% | 7.78B | |
+14.12% | 2.87B | |
-1.85% | 1.55B | |
-8.42% | 1.1B | |
+23.15% | 851M | |
-5.93% | 734M | |
-3.86% | 604M | |
-21.11% | 525M | |
-14.32% | 509M |
- Stock Market
- Equities
- TTT Stock
- Financials Met.Extra Group S.p.A.